Literature DB >> 17030554

Haplotypes spanning SPEC2, PDZ-GEF2 and ACSL6 genes are associated with schizophrenia.

Xiangning Chen1, Xu Wang, Shaon Hossain, F Anthony O'Neill, Dermot Walsh, Lora Pless, Kodavali V Chowdari, Vishwajit L Nimgaonkar, Sibylle G Schwab, Dieter B Wildenauer, Patrick F Sullivan, Edwin van den Oord, Kenneth S Kendler.   

Abstract

Chromosome 5q22-33 is a region where studies have repeatedly found evidence for linkage to schizophrenia. In this report, we took a stepwise approach to systematically map this region in the Irish Study of High Density Schizophrenia Families (ISHDSF, 267 families, 1337 subjects) sample. We typed 289 SNPs in the critical interval of 8 million basepairs and found a 758 kb interval coding for the SPEC2/PDZ-GEF2/ACSL6 genes to be associated with the disease. Using sex and genotype-conditioned transmission disequilibrium test analyses, we found that 19 of the 24 typed markers were associated with the disease and the associations were sex-specific. We replicated these findings with an Irish case-control sample (657 cases and 414 controls), an Irish parent-proband trio sample (187 families, 564 subjects), a German nuclear family sample (211 families, 751 subjects) and a Pittsburgh nuclear family sample (247 families, 729 subjects). In all four samples, we replicated the sex-specific associations at the levels of both individual markers and haplotypes using sex- and genotype-conditioned analyses. Three risk haplotypes were identified in the five samples, and each haplotype was found in at least two samples. Consistent with the discovery of multiple estrogen-response elements in this region, our data showed that the impact of these haplotypes on risk for schizophrenia differed in males and females. From these data, we concluded that haplotypes underlying the SPEC2/PDZ-GEF2/ACSL6 region are associated with schizophrenia. However, due to the extended high LD in this region, we were unable to distinguish whether the association signals came from one or more of these genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030554     DOI: 10.1093/hmg/ddl409

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  28 in total

1.  Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia.

Authors:  Jingchun Chen; Grace Lee; Ayman H Fanous; Zhongming Zhao; Peilin Jia; Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2011-07-14       Impact factor: 4.939

2.  CANDID: a flexible method for prioritizing candidate genes for complex human traits.

Authors:  Janna E Hutz; Aldi T Kraja; Howard L McLeod; Michael A Province
Journal:  Genet Epidemiol       Date:  2008-12       Impact factor: 2.135

3.  FBXL21 association with schizophrenia in Irish family and case-control samples.

Authors:  Xiangning Chen; Xu Wang; Cuie Sun; Qi Chen; F Anthony O'Neill; Dermot Walsh; Ayman Fanous; Kenneth S Kendler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

4.  Acyl-CoA synthetase 6 enriches the neuroprotective omega-3 fatty acid DHA in the brain.

Authors:  Regina F Fernandez; Sora Q Kim; Yingwei Zhao; Rachel M Foguth; Marcus M Weera; Jessica L Counihan; Daniel K Nomura; Julia A Chester; Jason R Cannon; Jessica M Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-06       Impact factor: 11.205

5.  Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia?

Authors:  Qi Chen; Xu Wang; Francis A O'Neill; Dermot Walsh; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-16       Impact factor: 4.939

6.  Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Authors:  Todd L Edwards; Xu Wang; Qi Chen; Brandon Wormly; Brien Riley; F Anthony O'Neill; Dermot Walsh; Marylyn D Ritchie; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-18       Impact factor: 4.939

7.  A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder.

Authors:  Jubao Duan; Jianxin Shi; Alessia Fiorentino; Catherine Leites; Xiangning Chen; Winton Moy; Jingchun Chen; Boian S Alexandrov; Anny Usheva; Deli He; Jessica Freda; Niamh L O'Brien; Andrew McQuillin; Alan R Sanders; Elliot S Gershon; Lynn E DeLisi; Alan R Bishop; Hugh M D Gurling; Michele T Pato; Douglas F Levinson; Kenneth S Kendler; Carlos N Pato; Pablo V Gejman
Journal:  Am J Hum Genet       Date:  2014-11-26       Impact factor: 11.025

8.  GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia.

Authors:  X Chen; G Lee; B S Maher; A H Fanous; J Chen; Z Zhao; A Guo; E van den Oord; P F Sullivan; J Shi; D F Levinson; P V Gejman; A Sanders; J Duan; M J Owen; N J Craddock; M C O'Donovan; J Blackman; D Lewis; G K Kirov; W Qin; S Schwab; D Wildenauer; K Chowdari; V Nimgaonkar; R E Straub; D R Weinberger; F A O'Neill; D Walsh; M Bronstein; A Darvasi; T Lencz; A K Malhotra; D Rujescu; I Giegling; T Werge; T Hansen; A Ingason; M M Nöethen; M Rietschel; S Cichon; S Djurovic; O A Andreassen; R M Cantor; R Ophoff; A Corvin; D W Morris; M Gill; C N Pato; M T Pato; A Macedo; H M D Gurling; A McQuillin; J Pimm; C Hultman; P Lichtenstein; P Sklar; S M Purcell; E Scolnick; D St Clair; D H R Blackwood; K S Kendler
Journal:  Mol Psychiatry       Date:  2010-09-14       Impact factor: 15.992

9.  Functional analysis of upstream common polymorphisms of the dopamine transporter gene.

Authors:  Mikhil N Bamne; Michael E Talkowski; Kodavali V Chowdari; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2009-03-09       Impact factor: 9.306

10.  Apoptotic engulfment pathway and schizophrenia.

Authors:  Xiangning Chen; Cuie Sun; Qi Chen; F Anthony O'Neill; Dermot Walsh; Ayman H Fanous; Kodavali V Chowdari; Vishwajit L Nimgaonkar; Adrian Scott; Sibylle G Schwab; Dieter B Wildenauer; Ronglin Che; Wei Tang; Yongyong Shi; Lin He; Xiong-Jian Luo; Bing Su; Todd L Edwards; Zhongming Zhao; Kenneth S Kendler
Journal:  PLoS One       Date:  2009-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.